VuceticAdriana Max Planck Institute for Lung and Heart ResearchGermany

VuceticAdriana
Since August 2018, Adriana Vucetic has been conducting doctoral research at the Max Planck Institute for Heart and Lung Research in Bad Nauheim, Germany, under the supervision of Prof. Dr. Stefan Offermanns. Her research is centered on the role of erythrocyte signaling pathways in metastasis, with the objective of elucidating novel mechanisms in cancer progression. Concurrently, from 2018 to 2021, she was enrolled in the International Max Planck Research School for Molecular Organ Biology. Since May 2023, she has been supervising students for laboratory internships and master's theses. Adriana earned her Master's degree in Molecular Biology from the Faculty of Science, University of Zagreb, Croatia, in 2017, following her Bachelor's degree, completed in 2015. In 2017, she engaged in an international internship at the Stagljar Lab at the University of Toronto, Canada, where she focused on the mapping and functional characterization of the ErbB receptor tyrosine kinase family in the context of malignant transformations. From 2013 to 2017, she particiapted in a series of internships and teaching positions at the University of Zagreb. These roles encompassed areas such as molecular genetics, zoology, and laboratory animal research. Beyond the lab, Adriana has been actively involved in academic service and student representation. She served as coordinator of the Max Planck PhDnet Survey Group from 2021 to 2023, was a PhD committee member from 2019 to 2021, and acted as the external PhD representative at the Max Planck Institute-HLR from 2021 to 2022.

Early Career Symposium

Time Session
16:10
17:40
(Separate pre-registration required)
TichetMelanie Chair Switzerland
  • Reprogramming immunosuppressive tumor-associated macrophages potentiates standard-of-care therapy in melanoma
    TichetMelanie Speaker Switzerland
  • Proffered Paper 3: SoxC transcription factors are oncoembryonic regulators of colon development and cancer
    DalessiTosca Presenter Switzerland
  • Proffered Paper 4: Erythrocyte-derived sphingosine-1-phosphate promotes tumor cell survival in the circulation
    VuceticAdriana Presenter Germany
  • Therapeutic OVERactivation of oncogenic signaling as a cancer treatment strategy
    dos Santos DiasMatheus Speaker The Netherlands
Auditorium VIII